These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 34387892)
1. Pilot study of universal screening of children and child-parent cascade testing for familial hypercholesterolaemia in Australia. Martin AC; Hooper AJ; Norman R; Nguyen LT; Burnett JR; Bell DA; Brett T; Garton-Smith J; Pang J; Nowak KJ; Watts GF J Paediatr Child Health; 2022 Feb; 58(2):281-287. PubMed ID: 34387892 [TBL] [Abstract][Full Text] [Related]
3. Parent-child genetic testing for familial hypercholesterolaemia in an Australian context. Pang J; Martin AC; Bates TR; Hooper AJ; Bell DA; Burnett JR; Norman R; Watts GF J Paediatr Child Health; 2018 Jul; 54(7):741-747. PubMed ID: 29626384 [TBL] [Abstract][Full Text] [Related]
4. Integration of child-parent screening and cascade testing for familial hypercholesterolaemia. Wald DS; Wald NJ J Med Screen; 2019 Jun; 26(2):71-75. PubMed ID: 30319009 [TBL] [Abstract][Full Text] [Related]
5. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029 [TBL] [Abstract][Full Text] [Related]
6. Reverse cascade screening for familial hypercholesterolemia in high-risk Chinese families. Wu X; Pang J; Wang X; Peng J; Chen Y; Wang S; Watts GF; Lin J Clin Cardiol; 2017 Nov; 40(11):1169-1173. PubMed ID: 29168983 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience. Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028 [TBL] [Abstract][Full Text] [Related]
8. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Wiegman A; Gidding SS; Watts GF; Chapman MJ; Ginsberg HN; Cuchel M; Ose L; Averna M; Boileau C; Borén J; Bruckert E; Catapano AL; Defesche JC; Descamps OS; Hegele RA; Hovingh GK; Humphries SE; Kovanen PT; Kuivenhoven JA; Masana L; Nordestgaard BG; Pajukanta P; Parhofer KG; Raal FJ; Ray KK; Santos RD; Stalenhoef AF; Steinhagen-Thiessen E; Stroes ES; Taskinen MR; Tybjærg-Hansen A; Wiklund O; Eur Heart J; 2015 Sep; 36(36):2425-37. PubMed ID: 26009596 [TBL] [Abstract][Full Text] [Related]
9. Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2022; 22(3):1-155. PubMed ID: 36158868 [TBL] [Abstract][Full Text] [Related]
10. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies. Nherera L; Marks D; Minhas R; Thorogood M; Humphries SE Heart; 2011 Jul; 97(14):1175-81. PubMed ID: 21685482 [TBL] [Abstract][Full Text] [Related]
11. Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC). Futema M; Cooper JA; Charakida M; Boustred C; Sattar N; Deanfield J; Lawlor DA; Timpson NJ; ; Humphries SE; Hingorani AD Atherosclerosis; 2017 May; 260():47-55. PubMed ID: 28349888 [TBL] [Abstract][Full Text] [Related]
13. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia. Ademi Z; Watts GF; Pang J; Sijbrands EJ; van Bockxmeer FM; O'Leary P; Geelhoed E; Liew D J Clin Lipidol; 2014; 8(4):390-400. PubMed ID: 25110220 [TBL] [Abstract][Full Text] [Related]
14. Detecting familial hypercholesterolemia: An observational study leveraging mandatory universal pediatric total cholesterol screening in Slovakia. Raslova K; Donicova V; Gonova K; Klabnik A; Tichy L; Bridges I; Buckova D; Zachlederova M; Freiberger T; Vohnout B J Clin Lipidol; 2024; 18(4):e537-e547. PubMed ID: 38955586 [TBL] [Abstract][Full Text] [Related]
15. Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis. McKay AJ; Hogan H; Humphries SE; Marks D; Ray KK; Miners A Atherosclerosis; 2018 Aug; 275():434-443. PubMed ID: 29937236 [TBL] [Abstract][Full Text] [Related]
16. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families. Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076 [TBL] [Abstract][Full Text] [Related]
17. Improving the detection of familial hypercholesterolaemia. Lan NSR; Martin AC; Brett T; Watts GF; Bell DA Pathology; 2019 Feb; 51(2):213-221. PubMed ID: 30579649 [TBL] [Abstract][Full Text] [Related]
18. Parental Attitudes and Ideas Regarding Newborn Screening for Familial Hypercholesterolemia. Tobik K; Orland KM; Zhang X; Garcia K; Peterson AL Matern Child Health J; 2023 Jun; 27(6):978-983. PubMed ID: 36964843 [TBL] [Abstract][Full Text] [Related]
19. Progress in the care of familial hypercholesterolaemia: 2016. Bell DA; Watts GF Med J Aust; 2016 Sep; 205(5):232-6. PubMed ID: 27581271 [TBL] [Abstract][Full Text] [Related]
20. Detecting familial hypercholesterolemia earlier in life by actively searching for affected children:The DECOPIN project. Ibarretxe D; Rodríguez-Borjabad C; Feliu A; Bilbao JÁ; Masana L; Plana N Atherosclerosis; 2018 Nov; 278():210-216. PubMed ID: 30312929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]